BenchSci Public Market Comparables
Find the most relevant public market comparables for BenchSci, including EV/Revenue and EV/EBITDA multiples to help you make informed investment decisions.
Company Overview
BenchSci develops ASCEND, an AI-powered platform that helps scientists accelerate drug discovery and improve patient outcomes by providing an unmatched understanding of disease biology. It uses machine learning and artificial intelligence to translate both closed and open-access data into recommendations for specific experiments, enabling researchers to run successful experiments faster and more efficiently.
Business Model
Software as a Service (SaaS) providing an AI-driven platform for drug discovery research.
Target Customers
Pharmaceutical companies, research institutions, and scientists involved in preclinical drug discovery.
Specific Focus
AI-powered drug discovery platform focusing on preclinical research and reagent selection.
Location
Toronto, Ontario
CEO
Liran Belenzon
Industry
Life sciences
Sub Sector
Biotechnology, Pharmaceutical Research
3yr Revenue Growth
743%
Website
Public Market Comparables
Below are the key valuation metrics for companies similar to BenchSci in the Life Sciences sector. These metrics can help you understand how the market values companies with similar business models and growth profiles.
Looking for a comprehensive compset for BenchSci? Our platform provides detailed analysis of BenchSci's competitive landscape, including financial metrics, growth trends, and market positioning. Get access to the full BenchSci compset by trying our platform today.
EV/Revenue Multiple
Min
0.0x
Median
0.0x
Max
00.0x
Unlock actual values by trying our platform
View Full DetailsEV/EBITDA Multiple
Min
00.0x
Median
00.0x
Max
00.0x
Unlock actual values by trying our platform
View Full Details
Unlock the Full BenchSci Compset
As a leading player in the Life sciences industry within the Life Sciences sector, BenchSci operates in the specialized Biotechnology, Pharmaceutical Research sub-sector. Understanding how BenchSci compares to its public market comps is essential for accurate valuation and strategic decision-making.
Our comprehensive analysis includes detailed comparables (compsets) featuring similar companies in the Biotechnology, Pharmaceutical Research space, with complete financial metrics, growth trajectories, and competitive positioning insights that go beyond the surface-level data shown above.
Other Interesting Companies
MindBridge Analytics
Financial Software • Software & services
MindBridge Analytics develops AI-powered financial analytics software for audit, assurance, and commercial enterprise firms. Its software uses machine learning and artificial intelligence to detect anomalies in financial datasets, generating risk-weighted analysis and insights to improve decision-making and strengthen controls.
TradingView
Financial Technology (Fintech) • Fintech
TradingView is a social media network, social trading network, financial analysis platform, and mobile app for traders and investors. It offers web-based charting, analytics, and trading software with social features for communication, aggregating web stock charts and offering free access to charting and analysis, enabling users to publish trading ideas and discuss markets.
Recursion Pharmaceuticals, Inc.
Healthcare • Life sciences
Recursion Pharmaceuticals, Inc. is a clinical-stage TechBio company decoding biology and chemistry to industrialize drug discovery. It uses an integrated AI-enabled full-stack platform, the Recursion Operating System (OS), to map and navigate biological and chemical relationships, accelerating the identification of potential drug treatments. The company focuses on oncology and rare diseases.
Get Your Custom Comparable Analysis
Need a more detailed analysis of BenchSci and its public market comparables? Our platform provides comprehensive valuation metrics, growth analysis, and more.
Try CompsetFinder Free